On 27 December 2022 the President of the Agency for Health Technology Assessment and Tariff System issued the following opinion:
Opinion No. 67/2022 of 27 December 2022 of the President of the Agency for Health Technology Assessment and Tariff System on the draft health policy programme – “Health policy programme in the area of mandatory and recommended vaccinations with the use of the ‘6 in1’ high-dose vaccine”